chr1-6555479-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_138697.4(TAS1R1):c.106G>A(p.Gly36Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0001 in 1,592,074 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000097 ( 0 hom. )
Consequence
TAS1R1
NM_138697.4 missense
NM_138697.4 missense
Scores
7
9
2
Clinical Significance
Conservation
PhyloP100: 4.38
Genes affected
TAS1R1 (HGNC:14448): (taste 1 receptor member 1) The protein encoded by this gene is a G protein-coupled receptor and is a component of the heterodimeric amino acid taste receptor T1R1+3. The T1R1+3 receptor responds to L-amino acids but not to D-enantiomers or other compounds. Most amino acids that are perceived as sweet activate T1R1+3, and this activation is strictly dependent on an intact T1R1+3 heterodimer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS1R1 | NM_138697.4 | c.106G>A | p.Gly36Arg | missense_variant | 1/6 | ENST00000333172.11 | NP_619642.2 | |
TAS1R1 | NM_177540.3 | c.106G>A | p.Gly36Arg | missense_variant | 1/5 | NP_803884.1 | ||
TAS1R1 | XM_011542206.3 | c.106G>A | p.Gly36Arg | missense_variant | 1/6 | XP_011540508.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS1R1 | ENST00000333172.11 | c.106G>A | p.Gly36Arg | missense_variant | 1/6 | 1 | NM_138697.4 | ENSP00000331867 | P1 | |
TAS1R1 | ENST00000351136.7 | c.106G>A | p.Gly36Arg | missense_variant | 1/5 | 2 | ENSP00000312558 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152202Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
20
AN:
152202
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000234 AC: 49AN: 209530Hom.: 0 AF XY: 0.000230 AC XY: 26AN XY: 113078
GnomAD3 exomes
AF:
AC:
49
AN:
209530
Hom.:
AF XY:
AC XY:
26
AN XY:
113078
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000972 AC: 140AN: 1439872Hom.: 0 Cov.: 31 AF XY: 0.0000910 AC XY: 65AN XY: 714412
GnomAD4 exome
AF:
AC:
140
AN:
1439872
Hom.:
Cov.:
31
AF XY:
AC XY:
65
AN XY:
714412
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152202Hom.: 0 Cov.: 34 AF XY: 0.000134 AC XY: 10AN XY: 74350
GnomAD4 genome
AF:
AC:
20
AN:
152202
Hom.:
Cov.:
34
AF XY:
AC XY:
10
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.106G>A (p.G36R) alteration is located in exon 1 (coding exon 1) of the TAS1R1 gene. This alteration results from a G to A substitution at nucleotide position 106, causing the glycine (G) at amino acid position 36 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Loss of sheet (P = 0.0357);Loss of sheet (P = 0.0357);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at